Treatment of acute gynecologic infections with trovafloxacin
- 31 December 1998
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Surgery
- Vol. 176 (6) , 67S-73S
- https://doi.org/10.1016/s0002-9610(98)00223-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacinThe American Journal of Surgery, 1998
- Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin.Journal of Antimicrobial Chemotherapy, 1997
- In-vitro activity of trovafloxacin (CP99,219) tested by two methods against 150 vancomycin-resistant enterococcal isolatesJournal of Antimicrobial Chemotherapy, 1996
- In vitro activity of the new fluoroquinolone CP-99,219Antimicrobial Agents and Chemotherapy, 1994
- In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1993
- Evaluation of New Anti-Infective Drugs for the Treatment of Acute Pelvic Infections in Hospitalized WomenClinical Infectious Diseases, 1992
- Technique for calculation of the true costs of antibiotic therapyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Patient costs for prophylaxis and treatment of obstetric and gynecologic surgical infectionsAmerican Journal of Obstetrics and Gynecology, 1991
- Multicenter comparison of cefotetan and cefoxitin in the treatment of acute obstetric and gynecologic infectionsAmerican Journal of Obstetrics and Gynecology, 1988
- Ampicillin/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infectionsAmerican Journal of Obstetrics and Gynecology, 1987